Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome

Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome

Abstract Viruses are the most abundant components of the human gut microbiome with a significant impact on health and disease. The effects of human immunodeficiency virus (HIV) infection on gut virome has been scarcely analysed. Several studies suggested that integrase strand transfers inhibitors (I...

Full description

Bibliographic Details
Main Authors:	Pablo Villoslada-Blanco, Patricia Pérez-Matute, María Íñiguez, Emma Recio-Fernández, Daan Jansen, Lander De Coninck, Lila Close, Pilar Blanco-Navarrete, Luis Metola, Valvanera Ibarra, Jorge Alba, Jelle Matthijnssens, José A. Oteo
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-12-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-25979-5

Similar Items

Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome
by: Pablo Villoslada-Blanco, et al.
Published: (2023-08-01)

The Emerging Role of the Gut Virome in Health and Inflammatory Bowel Disease: Challenges, Covariates and a Viral Imbalance
by: Daan Jansen, et al.
Published: (2023-01-01)

<i>Aedes</i> Mosquito Virome in Southwestern Cameroon: Lack of Core Virome, But a Very Rich and Diverse Virome in <i>Ae. africanus</i> Compared to Other <i>Aedes</i> Species
by: Karelle Celes Mbigha Donfack, et al.
Published: (2024-07-01)

Lack of abundant core virome in Culex mosquitoes from a temperate climate region despite a mosquito species-specific virome
by: Lander De Coninck, et al.
Published: (2024-06-01)

Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study
by: José Ramón Santos, et al.
Published: (2023-06-01)

A Previously Undescribed Highly Prevalent Phage Identified in a Danish Enteric Virome Catalog
by: Lore Van Espen, et al.
Published: (2021-10-01)

HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
by: Emma G. Foster, et al.
Published: (2022-12-01)

Towards quantitative viromics for both double-stranded and single-stranded DNA viruses
by: Simon Roux, et al.
Published: (2016-12-01)

Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs
by: Steven J. Smith, et al.
Published: (2021-01-01)

Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China
by: Huan Xia, et al.
Published: (2023-11-01)

Different Pathways Conferring Integrase Strand-Transfer Inhibitors Resistance
by: Clémence Richetta, et al.
Published: (2022-11-01)

HIV drug resistance against strand transfer integrase inhibitors
by: Kaitlin Anstett, et al.
Published: (2017-06-01)

Characterization of the Human Blood Virome in Iranian Multiple Transfused Patients
by: Marijn Thijssen, et al.
Published: (2023-06-01)

Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors
by: Emma G. Foster, et al.
Published: (2023-02-01)

In Silico and In Vitro Comparison of HIV-1 Subtypes B and CRF02_AG Integrases Susceptibility to Integrase Strand Transfer Inhibitors
by: Xiaoju Ni, et al.
Published: (2012-01-01)

First Report of Human Granulocytic Ehrlichiosis from Southern Europe (Spain)
by: José A. Oteo, et al.
Published: (2000-08-01)

Epidemiological, Clinical, and Microbiological Characteristics in a Large Series of Patients Affected by <i>Dermacentor</i>-Borne-Necrosis-Erythema-Lymphadenopathy from a Unique Centre from Spain
by: Sonia Santibáñez, et al.
Published: (2022-04-01)

A single-stranded based library preparation method for virome characterization
by: Xichuan Zhai, et al.
Published: (2024-10-01)

Plasma virome dynamics in chronic hepatitis B virus infected patients
by: Marijn Thijssen, et al.
Published: (2023-05-01)

From protease inhibitors to integrase strand transfer inhibitors: the evolution of HIV drug resistance management
by: HU Zhiliang, YANG Yongfeng
Published: (2025-01-01)

Incidence of cardiometabolic outcomes among people living with HIV‐1 initiated on integrase strand transfer inhibitor versus non‐integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States
by: Peter F. Rebeiro, et al.
Published: (2023-06-01)

Comparative Analyses of Antiviral Potencies of Second-Generation Integrase Strand Transfer Inhibitors (INSTIs) and the Developmental Compound 4d Against a Panel of Integrase Quadruple Mutants
by: Steven J. Smith, et al.
Published: (2025-01-01)

Resistance mutations outside the integrase coding region have an effect on human immunodeficiency virus replicative fitness but do not affect its susceptibility to integrase strand transfer inhibitors.
by: Jan Weber, et al.
Published: (2013-01-01)

The Discovery of Indole-2-carboxylic Acid Derivatives as Novel HIV-1 Integrase Strand Transfer Inhibitors
by: Yu-Chan Wang, et al.
Published: (2023-12-01)

Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures
by: Hubert Monnerie, et al.
Published: (2023-12-01)

Drug Resistance to Integrase Strand-Transfer Inhibitors among HIV-1-Infected Adults in Guangdong, China
by: Yun Lan, et al.
Published: (2022-11-01)

No transmitted drug resistance to HIV integrase strand-transfer inhibitors after their scale-up in Estonia in 2017
by: Arina Šablinskaja, et al.
Published: (2023-06-01)

Inhibition of HTLV-1 Infection by HIV-1 First- and Second-Generation Integrase Strand Transfer Inhibitors
by: Michał S. Barski, et al.
Published: (2019-08-01)

Integrase and integration: biochemical activities of HIV-1 integrase
by: Deprez Eric, et al.
Published: (2008-12-01)

Clinical Outcomes of Integrase Strand Transfer Inhibitors Containing Antiretroviral Therapy in HIV-2: A Narrative Review
by: Wendy J. Boschloo, et al.
Published: (2024-05-01)

A Practical Approach to Bicyclic Carbamoyl Pyridones with Application to the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors
by: Pankaj S. Mahajan, et al.
Published: (2023-02-01)

Factors associated with HIV-1 resistance to integrase strand transfer inhibitors in Spain: Implications for dolutegravir-containing regimens
by: Horacio Gil, et al.
Published: (2022-12-01)

A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection
by: Alexa Vyain Zhao, et al.
Published: (2022-10-01)

Characterization of the long-terminal repeat single-strand tail-binding site of Moloney-MuLV integrase by crosslinking
by: JORGE VERA, et al.
Published: (2008-01-01)

Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa
by: Inzaule, SC, et al.
Published: (2018)

Prevalence and analysis of acquired and transmitted integrase strand transfer inhibitor-associated HIV-1 drug resistance in Chongqing, China
by: Huizheng Zhang, et al.
Published: (2023-12-01)

META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports
by: Milena M Murray, et al.
Published: (2023-08-01)

Effects of different integrase strand transfer inhibitors on body weight in patients with HIV/AIDS: a network meta-analysis
by: Ruojing Bai, et al.
Published: (2022-02-01)

Highly divergent CRESS DNA and picorna-like viruses associated with bleached thalli of the green seaweed Ulva
by: Luna M. van der Loos, et al.
Published: (2023-10-01)

DNA virome of ticks in the Northeast and Hubei provinces of China reveals diverse single-stranded circular DNA viruses
by: Yuhang Liu, et al.
Published: (2023-02-01)